Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLOBE-SpA - GuseLkumab for Overlap Inflammatory Bowel DiseasE and Spondyloarthritis

NCT07602517 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07602517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLOBE-SpA - GuseLkumab for Overlap Inflammatory Bowel DiseasE and Spondyloarthritis
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Not yet recruiting
Start date
May 20, 2026
Completion date
May 20, 2029
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, spondyloarthritis